Antiarrhythmogenic and antioxidant effect of the flavonoid dioclein in a model of cardiac ischemia/reperfusion.

Planta Med

Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Published: March 2006

The antiarrhythmogenic effect of the flavonoid dioclein on myocardial ischemia/reperfusion was investigated in isolated perfused rat hearts. Low concentrations of dioclein (30-300 nM) induced a reduction of arrhythmias observed during the reperfusion period. Dioclein also preserved the diastolic tension after reperfusion without affecting the systolic tension. In addition, dioclein (150 nM) dramatically reduced the formation of reactive oxygen species (ROS) observed during reperfusion in hearts. In conclusion, dioclein acts as a potent antiarrhythmogenic and antioxidant drug with an excellent protective effect during reperfusion of ischemic hearts.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2005-916218DOI Listing

Publication Analysis

Top Keywords

antiarrhythmogenic antioxidant
8
flavonoid dioclein
8
observed reperfusion
8
dioclein
6
antioxidant flavonoid
4
dioclein model
4
model cardiac
4
cardiac ischemia/reperfusion
4
ischemia/reperfusion antiarrhythmogenic
4
antiarrhythmogenic flavonoid
4

Similar Publications

Isorhamnetin, a natural flavonoid, has strong antioxidant and antifibrotic effects, and a regulatory effect against Ca2+-handling. Atrial remodeling due to fibrosis and abnormal intracellular Ca2+ activities contributes to initiation and persistence of atrial fibrillation (AF). The present study investigated the effect of isorhamnetin on angiotensin II (AngII)-induced AF in mice.

View Article and Find Full Text PDF

L. as a Nutritional Strategy for Cardioprotection.

Front Physiol

April 2021

Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

This review aimed to provide a summary on the traditional uses, phytochemistry, and pharmacological activities in the cardiovascular system and cardiotoxicity of (MO), with the special emphasis on the protective mechanisms in different cardiovascular pathologies. MO is a perennial aromatic herb commonly known as lemon balm, honey balm, or bee balm, which belongs to family. Active components are mainly located in the leaves or essential oil and include volatile compounds, terpenoid (monoterpenes, sesquiterpenes, triterpenes), and polyphenolic compounds [rosmarinic acid (RA), caffeic acid, protocatechuic acid, quercitrin, rhamnocitrin, luteolin].

View Article and Find Full Text PDF

The Impact of Omega 3 Fatty Acids in Atherosclerosis and Arterial Stiffness: An Overview of their Actions.

Curr Pharm Des

November 2019

Department of Cardiology, 'Hippokration` General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Background: Fatty acids are common dietary nutrients particularly in economically developed countries. Research has revealed that omega-3fatty acids exert beneficial effects in the progression of atherosclerosis and cardiovascular disease. Moreover, eicosapentaenoic acid and docosahexaenoic acid possess a number of biological actions which improve cardio-metabolic health.

View Article and Find Full Text PDF

Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats.

Biomed Pharmacother

September 2010

Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, 238, Jiefang Road, Wuchang, Wuhan 430060, PR China.

Background: We hypothesized that carvedilol, a nonselective β-blocker, can exert antiarrhythmogenic effects by inhibiting sympathetic nerve sprouting and electrical remodeling at peri-infarct zones after myocardial infarction (MI).

Methods: MI was induced by ligation of the coronary artery. The rats in the carvedilol group received 5.

View Article and Find Full Text PDF

Objectives: This study analyzed the antiarrhythmogenic effect of reconstituted high-density lipoprotein (rHDL) against ischemia/reperfusion in vivo.

Background: Recent studies have suggested that a reduction in the plasma HDL level may contribute to cardiac sudden death. Although there are currently only a few therapeutic strategies for increasing HDL, an exciting new therapeutic option, rHDL, has recently been developed to prevent coronary artery disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!